Package 0615-8300-05

{"route": ["ORAL"], "spl_id": "e4fa3743-ceaf-46a5-b02c-954fe5944e5b", "openfda": {"nui": ["N0000008553", "N0000175911"], "unii": ["EOR26LQQ24"], "rxcui": ["349556"], "spl_set_id": ["f30c3cb1-fb91-4f69-b181-bfb4238635af"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "pharm_class_epc": ["Dietary Cholesterol Absorption Inhibitor [EPC]"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET in 1 BLISTER PACK (0615-8300-05)", "package_ndc": "0615-8300-05", "marketing_end_date": "20260228", "marketing_start_date": "20230831"}, {"sample": false, "description": "30 TABLET in 1 BLISTER PACK (0615-8300-39)", "package_ndc": "0615-8300-39", "marketing_end_date": "20260228", "marketing_start_date": "20190703"}], "brand_name": "Ezetimibe", "product_id": "0615-8300_e4fa3743-ceaf-46a5-b02c-954fe5944e5b", "dosage_form": "TABLET", "pharm_class": ["Decreased Cholesterol Absorption [PE]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "product_ndc": "0615-8300", "generic_name": "Ezetimibe", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ezetimibe", "active_ingredients": [{"name": "EZETIMIBE", "strength": "10 mg/1"}], "application_number": "ANDA209838", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20170825"}